The largest database of trusted experimental protocols

Substance p sp

Manufactured by Merck Group
Sourced in United States

Substance P (SP) is a neuropeptide that functions as a neurotransmitter or neuromodulator in the nervous system. It is primarily involved in the transmission of pain signals and the regulation of inflammation. SP plays a role in various physiological processes, including sensory perception, motor function, and autonomic regulation.

Automatically generated - may contain errors

4 protocols using substance p sp

1

Pharmacological Isolation of Pacemaker Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pharmacological cocktail used to synaptically isolate pacemaker neurons contained 20 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 10 μM DL-2-amino-5-phosphonovaleric acid (AP5), 1 μM strychnine, and 10 μM bicuculline (all from Sigma).
Substance P (SP, Sigma) and the μ opioid receptor agonist D-Ala2-N-Me-Phe4-Glycol5-enkephalin (DAMGO, Sigma) were dissolved in aCSF and bath-applied at their final concentration of 0.5 μM and 0.25 μM, respectively. A single modulatory drug was applied per preparation in order to avoid cross effects. Preparations were exposed to a drug for a 15 min period and its effects on respiratory rhythm cycle frequency were analyzed at the end of this period using Clampfit software (Molecular Devices). The reversal of any observed effects was tested for each drug after a 30 min period wash-out during which fresh aCSF was superfused in the recording chamber.
Values are given as mean ± SEM. Student's t tests with a Mann-Whitney Rank Sum test or ANOVA tests were used to assess differences (taken to be significant at P < 0.05) between values in the presence of the drugs and controls.
+ Open protocol
+ Expand
2

Microglial Phenotypical Changes Induced by Cytokines

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the phenotypical changes of microglia, MG d14 were pre-treated with 10 ng/mL GMCSF (R&D Systems, Minneapolis, MN, USA) for 5 days and then incubated with the following cytokines for 3 days: 10 ng/mL GMCSF (R&D systems, Minneapolis, MN, USA), 100 nM Substance P (SP, Sigma, St. Louis, MO, USA), 10 ng/mL rat IL-4 (R&D systems, Minneapolis, MN, USA), 10 ng/mL rat IL-10 (R&D systems, Minneapolis, MN, USA), 10 ng/mL TNF-α (Sigma, St. Louis, MO, USA), and 20 ng/mL IFN-γ (R&D systems, Minneapolis, MN, USA).
+ Open protocol
+ Expand
3

Achilles Tendon Injection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Injections were given in the loose connective tissue outside the Achilles tendon, i.e. in the paratenon region, of the right leg. The injections were given directly after each of the exercise regimens. The substances injected were Captopril (C) (c4042; Sigma), DL-Thiorphan (Th) (T 6031; Sigma), substance P (SP) (S6883; Sigma) and NaCl. Captopril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) and DL-Thiorphan inhibits the activity of neutral endopeptidase (NEP). NEP is also called enkephalinase and neprilysin or common acute lymphoblastic leukemia antigen or CD10 [29 (link)].
Injections were performed as follows: a) Substance P (10-8 μmol/ml) and Captopril (30 μmol/kg) both in distilled water (volume: 1 ml) + DL-Thiorphan (500 μg/ml; 0.02 ml) (5 animals), b) Captopril (30 μmol/kg, dissolved in distilled water, volume 1 ml) + DL-Thiorphan (500 μg/ml, 0.02 ml) (6 animals), c) NaCl (volume: 1 ml) (5 animals). The groups are further referred to as the SP + C + Th group, the C + Th group and the NaCl group.
+ Open protocol
+ Expand
4

Mouse Model of Uterine Regeneration

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments were performed in the in-house animal facility in accordance with the guidelines of the National Research Council’s Guide for the Care and Use of Laboratory Animals [34 ] and approved by the institutional experimental animals review board of Shanghai OB/GYN Hospital, Fudan University. A total of 60 female Balb/C mice, about 6–8 weeks old and about 18–21 g in bodyweight, were purchased from Shanghai LingChang Laboratory Animal Center (Shanghai, China) and used for this study. Among them, 20 were randomly selected as donors that contributed uterine fragments, and the remaining 40 were recipients.
The PNU-282987 and substance P (SP) were purchased from Sigma-Aldrich (St Louis, MO, USA), and methyllycaconitine citrate (MLA) from Abcam (Cambridge, UK). PNU-282987, MLA and SP were all dissolved in 0.9% sterile saline. As such, the control group used saline as a mock treatment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!